Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios

Renata Mojzikova, Pavla Koralkova, Dusan Holub, Zuzana Zidova, Dagmar Pospisilova, Jaroslav Cermak, Zuzana Striezencova Laluhova, Karel Indrak, Martina Sukova, Martina Partschova, Jana Kucerova, Monika Horvathova, Vladimir Divoky

. 2014 ; 165 (4) : 556-563.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14063714

Grantová podpora
NT11208 MZ0 CEP - Centrální evidence projektů
NT13587 MZ0 CEP - Centrální evidence projektů

Pyruvate kinase (PK) deficiency is an iron-loading anaemia characterized by chronic haemolysis, ineffective erythropoiesis and a requirement for blood transfusion in most cases. We studied 11 patients from 10 unrelated families and found nine different disease-causing PKLR mutations. Two of these mutations - the point mutation c.878A>T (p.Asp293Val) and the frameshift deletion c.1553delG (p.(Arg518Leufs*12)) - have not been previously described in the literature. This frameshift deletion was associated with an unusually severe phenotype involving neonatal hyperferritinaemia that is not typical of PK deficiency. No disease-causing mutations in genes associated with haemochromatosis could be found. Inappropriately low levels of hepcidin with respect to iron loading were detected in all PK-deficient patients with increased ferritin, confirming the predominant effect of accelerated erythropoiesis on hepcidin production. Although the levels of a putative hepcidin suppressor, growth differentiation factor-15, were increased in PK-deficient patients, no negative correlation with hepcidin was found. This result indicates the existence of another as-yet unidentified erythroid regulator of hepcidin synthesis in PK deficiency.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14063714
003      
CZ-PrNML
005      
20190919084620.0
007      
ta
008      
140704s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bjh.12779 $2 doi
035    __
$a (PubMed)24533562
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Mojzíková, Renáta $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $7 xx0140544
245    10
$a Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios / $c Renata Mojzikova, Pavla Koralkova, Dusan Holub, Zuzana Zidova, Dagmar Pospisilova, Jaroslav Cermak, Zuzana Striezencova Laluhova, Karel Indrak, Martina Sukova, Martina Partschova, Jana Kucerova, Monika Horvathova, Vladimir Divoky
520    9_
$a Pyruvate kinase (PK) deficiency is an iron-loading anaemia characterized by chronic haemolysis, ineffective erythropoiesis and a requirement for blood transfusion in most cases. We studied 11 patients from 10 unrelated families and found nine different disease-causing PKLR mutations. Two of these mutations - the point mutation c.878A>T (p.Asp293Val) and the frameshift deletion c.1553delG (p.(Arg518Leufs*12)) - have not been previously described in the literature. This frameshift deletion was associated with an unusually severe phenotype involving neonatal hyperferritinaemia that is not typical of PK deficiency. No disease-causing mutations in genes associated with haemochromatosis could be found. Inappropriately low levels of hepcidin with respect to iron loading were detected in all PK-deficient patients with increased ferritin, confirming the predominant effect of accelerated erythropoiesis on hepcidin production. Although the levels of a putative hepcidin suppressor, growth differentiation factor-15, were increased in PK-deficient patients, no negative correlation with hepcidin was found. This result indicates the existence of another as-yet unidentified erythroid regulator of hepcidin synthesis in PK deficiency.
650    _2
$a dospělí $7 D000328
650    _2
$a sekvence aminokyselin $7 D000595
650    _2
$a hemolytická nesférocytická kongenitální anemie $x krev $x genetika $7 D000746
650    _2
$a krevní transfuze $7 D001803
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a erytropoéza $7 D004920
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a ferritiny $x krev $7 D005293
650    _2
$a hepcidiny $x biosyntéza $x krev $7 D064451
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a železo $x krev $7 D007501
650    _2
$a přetížení železem $x genetika $7 D019190
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a molekulární sekvence - údaje $7 D008969
650    12
$a mutace $7 D009154
650    _2
$a pyruvátkinasa $x krev $x nedostatek $x genetika $7 D011770
650    _2
$a vrozené poruchy metabolismu pyruvátu $x krev $x genetika $7 D015323
650    _2
$a sekvenční analýza DNA $7 D017422
650    _2
$a mladý dospělý $7 D055815
650    _2
$a potransfuzní reakce $7 D065227
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kořalková, Pavla $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $7 xx0229679
700    1_
$a Holub, Dušan $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $7 xx0169439
700    1_
$a Židová, Zuzana $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $7 xx0207826
700    1_
$a Pospíšilová, Dagmar $u Department of Paediatrics, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $7 xx0052603
700    1_
$a Čermák, Jaroslav, $u Institute of Haematology and Blood Transfusion, Prague, Czech Republic $d 1954- $7 xx0053072
700    1_
$a Laluhová-Striežencová, Zuzana $u Children's Faculty Hospital with Policlinic, Bratislava, Slovak Republic $7 xx0265054
700    1_
$a Indrák, Karel, $u Department of Haemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $d 1947- $7 jn20000401162
700    1_
$a Suková, Martina $u Department of Paediatric Haematology and Oncology, University Hospital Motol, Prague, Czech Republic $7 xx0128868
700    1_
$a Partschová, Martina. $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $7 xx0239947
700    1_
$a Kučerová, Jana, $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $d 1982- $7 xx0153708
700    1_
$a Horváthová, Monika $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $7 ntk2011644397
700    1_
$a Divoký, Vladimír $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic; Department of Haemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $7 xx0018902
773    0_
$w MED00009374 $t British journal of haematology $x 1365-2141 $g Roč. 165, č. 4 (2014), s. 556-563
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24533562 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20190919085010 $b ABA008
999    __
$a ok $b bmc $g 1031198 $s 862446
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 165 $c 4 $d 556-563 $i 1365-2141 $m British journal of haematology $n Br J Haematol $x MED00009374
GRA    __
$a NT11208 $p MZ0
GRA    __
$a NT13587 $p MZ0
LZP    __
$a Pubmed-20140704

Najít záznam

Citační ukazatele

Možnosti archivace